Historical redlining and oral squamous cell carcinoma staging at diagnosis.

P Pei-Lun Kuo (3University of Maryland Medical Center - Midtown Campus, Baltimore, United States) L Lisa Mary Schumaker (Department of Oncology, University of Maryland School of Medicine, Baltimore, MD) O Olive Beyer (Department of Otorhinolaryngology-Head and Neck Surgery, Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD) R Raquel Rowell M Madeleine Ndahayo (University of Maryland, Baltimore, MD) M Meghan Lavigne (University of Maryland, Baltimore, MD) J Jennifer Coleman A Amy Jayne Plotkin (University of Maryland School of Medicine, Baltimore, MD) G Grace Snow (University of Maryland, Baltimore, MD) J Jeffrey S. Wolf (Department of Otorhinolaryngology, Baltimore, MD) R Rodney J. Taylor (University of Maryland School of Medicine, Baltimore, MD) D Donita Dyalram (University of Maryland Dental School, Baltimore, MD) J Joshua Lubek (University of Maryland Dental School, Baltimore, MD) K Kelly F. Moyer (University of Maryland School of Medicine, Department of Otorhinolaryngology, Baltimore, MD) K Kyle H. Hatten (University of Maryland, Baltimore, MD) R Ranee Mehra D Daria Gaykalova (Department of Otorhinolaryngology-Head and Neck Surgery Marlene & Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center Institute for Genome Sciences, Baltimore, MD) K Kathryn Barry (Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD)

Abstract

e22598 Background: Previous research has shown that residents in historically redlined zones, areas defined from the discriminatory housing policy in 1935-1940, are more prone to being diagnosed with later-stage cancer for breast cancer, cervical cancer, lung cancer, colorectal cancer, and prostate cancer. However, little was known about this relationship for oral squamous cell carcinoma, which lacks general screening guidelines at primary care settings and general practice incorporating oral cancer screening during routine dental care. Methods: We used cancer registry data from a single tertiary medical center mainly from year 2016-2025 to identify patients diagnosed with primary oral squamous cell carcinoma. Main exposure is whether the patient resided in historically redlining zone, defined as Homeowners’ Loan Corporation (HOLC) grades C and D. Main outcome of interest is the stage of oral squamous cell carcinoma, which is grouped as the binary outcome (late stages [stage III, IV] vs early stages [stages I, II]). Logistic regression is used to study the association between redlining and being diagnosed with late-stage oral squamous cell carcinoma. The data was visualized by a map incorporating the redlining zone and stages of oral squamous cell carcinoma at diagnosis. R version 4.2.3 is used for statistical analysis. Results: Among 566 patients diagnosed with primary oral squamous cell carcinoma, 232 (41%) are female, 105 (19%) are black/African American, and 39 lived in the historically redlining zone. The median age at diagnosis was younger among patients from redlined zones (median [IQR]: 59.81 [52.01, 63.84] ) compared to those from non-redlined zones (median [IQR]: 65.7 [57.94, 74.28] (p = 0.001). The unadjusted odds of a late-stage diagnosis were higher for patients in historically redlined zones (OR = 2.51, 95% CI = [1.18, 5.59]). Findings were similar after adjusting for sex, age, and smoking status(OR = 2.38, 95% CI = [1.11, 5.71]). Conclusions: The findings suggest that patients living in historically redlining zones are more likely to receive a late-stage diagnosis of oral squamous cell carcinoma and to be diagnosed at a relatively younger age. Findings indicate a need to increase resources, including increased dental care, in these areas to help identify cancers at an earlier stage and reduce disparities in oral squamous cell carcinoma outcomes. Further research and potential policy and/or public health initiatives targeting these populations for risk reduction and screening are warranted. Association between residing in historical redlining zone and odds of being stage III/IV oral squamous cell carcinoma at diagnosis. OR (95% CI ) Model 1: Unadjusted 2.51 [1.18, 5.95] Model 2: Adjusted for age 2.49 [1.17, 5.94] Model 3: Adjusted for age, sex 2.49 [1.17, 5.95] Model 4: Adjusted for age, sex, smoking status 2.38 [1.11, 5.71] OR = odds ratio; CI = confidence interval.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (18)

P

Pei-Lun Kuo

3University of Maryland Medical Center - Midtown Campus, Baltimore, United States

L

Lisa Mary Schumaker

Department of Oncology, University of Maryland School of Medicine, Baltimore, MD

O

Olive Beyer

Department of Otorhinolaryngology-Head and Neck Surgery, Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD

R

Raquel Rowell

M

Madeleine Ndahayo

University of Maryland, Baltimore, MD

M

Meghan Lavigne

University of Maryland, Baltimore, MD

J

Jennifer Coleman

A

Amy Jayne Plotkin

University of Maryland School of Medicine, Baltimore, MD

G

Grace Snow

University of Maryland, Baltimore, MD

J

Jeffrey S. Wolf

Department of Otorhinolaryngology, Baltimore, MD

R

Rodney J. Taylor

University of Maryland School of Medicine, Baltimore, MD

D

Donita Dyalram

University of Maryland Dental School, Baltimore, MD

J

Joshua Lubek

University of Maryland Dental School, Baltimore, MD

K

Kelly F. Moyer

University of Maryland School of Medicine, Department of Otorhinolaryngology, Baltimore, MD

K

Kyle H. Hatten

University of Maryland, Baltimore, MD

R

Ranee Mehra

D

Daria Gaykalova

Department of Otorhinolaryngology-Head and Neck Surgery Marlene & Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center Institute for Genome Sciences, Baltimore, MD

K

Kathryn Barry

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD